Takeda Pharmaceuticals North America (1076) of Deerfield, Ill., a wholly owned subsidiary of Takeda Pharmaceutical Company, is highlighting its pipeline with compounds in development for diabetes, cardiovascular disease and other conditions through the Takeda Global Research & Development Center.